EquityZen Growth Technology Fund LLC - Series 1060
Raised
$875K
Investors
42
Min Invest
$10,001
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1060 is a Delaware pooled investment fund filed by EquityZen Advisors LLC on 2022-01-26, raising $875K from 42 investors under Rule 506(b) and 3(c)(1) exemptions with a $10K minimum investment. This is one of approximately 1,889 series vehicles in the EquityZen platform, which provides access to pre-IPO technology company shares through individual SPV structures.
This pre-IPO fund follows the EquityZen platform's standard structure: a 506(b) exemption paired with 3(c)(1) for pooled investment vehicles, a $10K retail-accessible minimum, and a single-company focus typical of secondary marketplace SPVs. The $875K raise across 42 investors (~$21K average check) is consistent with retail-oriented secondary market access vehicles in this category.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
